Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TVT 2022

HALT and PVL

Presenter: Joao L. Cavalcante

June 09, 2022

TransJugular Mitral Valve-In-Valve in patient with Anomalous Inferior Vena Cava

Presentation TVT 2022

TransJugular Mitral Valve-In-Valve in patient with Anomalous Inferior Vena Cava

Presenter: Pradeep Yadav

June 09, 2022

Trans Jugular Mitral Valve-In-Valve in Patient With Anomalous Inferior Vena Cava

Presentation TVT 2022

Trans Jugular Mitral Valve-In-Valve in Patient With Anomalous Inferior Vena Cava

Presenter: Pradeep Yadav

June 09, 2022

Prognosticating With Imaging, Part 1: Leveraging TAVR CT Analysis for Patient Risk Stratification

Presentation TVT 2022

Prognosticating With Imaging, Part 1: Leveraging TAVR CT Analysis for Patient Risk Stratification

Presenter: Joao Cavalcante

June 08, 2022

Case-based Risk Stratification: Bridge too Far – Role of Multi-modality Assessment for Patient Selection

Presentation TVT 2022

Case-based Risk Stratification: Bridge too Far – Role of Multi-modality Assessment for Patient Selection

Presenter: Joao Cavalcante

June 08, 2022

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

July 22, 2021

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

June 19, 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

June 17, 2019

Case 6: A Difficult Case Treated With Caval Valves

Presentation TVT 2019

Case 6: A Difficult Case Treated With Caval Valves

Presenter: Alexander Lauten

June 14, 2019

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

June 16, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.